Associated Papers
Advancements in the research of the structure, function, and disease-related roles of ARMC5.
Qu Y et al.
Frontiers of Medicine, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.
Bouys L et al.
Orphanet Journal of Rare Diseases, 2025
Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease.
Cavalcante IP et al.
Nature Reviews. Endocrinology, 2022
Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients.
Bouys L et al.
European Journal of Endocrinology, 2022
Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation.
Cavalcante IP et al.
Endocrine-related Cancer, 2020
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
Albiger NM et al.
Endocrine, 2017
iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.
Wang M et al.
Scientific Reports, 2016
27527004 (PubMed )
Supplement: srep31321-s3.xls › NovelVar
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
Espiard S et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
Select a paper to view details